TAK Stock Price Prediction 2026-2027
AI-powered forecast for Takeda Pharmaceutical Co Ltd
Based on Wall Street consensus estimate - Medium Confidence
Current Price
$17.82
Price Targets for 2027
Bear Case
$18.97
+6.5%
Base Case
$20.53
+15.2%
Bull Case
$22.09
+24.0%
Prediction Tracking
Coming Soon for TAK
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for TAK
Key Factors Influencing TAK Stock
Bullish Factors
- Revenue growth of 0.0% year-over-year
- Significant upside potential to bull case target
- Market position and competitive advantages
Risk Factors
- High P/E ratio of 80.8x may limit upside
- Market volatility and macroeconomic factors
- Competitive pressures in Pharmaceuticals
Prediction Methodology
These predictions are based on the Wall Street consensus price target of $20.53.
Bull and bear cases are calculated with a reasonable spread around the consensus based on historical volatility.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for TAK
Frequently Asked Questions
What is TAK stock price today?
TAK (Takeda Pharmaceutical Co Ltd) stock is trading at $17.82 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is TAK stock going up or down today?
TAK stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy TAK stock now?
The decision to buy TAK depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is TAK a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for TAK based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is TAK stock overvalued or undervalued?
TAK currently trades at a P/E ratio of 80.82, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if TAK is fairly priced.
What is TAK's P/E ratio?
TAK has a price-to-earnings (P/E) ratio of 80.82, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is TAK's market cap?
TAK (Takeda Pharmaceutical Co Ltd) has a market capitalization of $56.17 billion, making it a mid-cap stock.
What is TAK's price to book ratio?
TAK trades at a price-to-book (P/B) ratio of 1.17, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Does TAK pay dividends?
Yes, TAK pays dividends with a current yield of 0.04%. Dividend payments provide income for investors in addition to potential stock price appreciation.
What is TAK's dividend yield?
TAK's dividend yield is 0.04%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.
Is TAK stock a good long-term investment?
TAK's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is TAK's revenue growth rate?
TAK has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.
Is TAK profitable?
Yes, TAK is profitable with a profit margin of 0.0%. This indicates the company generates 0.0 cents of profit for every dollar of revenue.
What are the risks of investing in TAK?
Key risks for TAK include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does TAK compare to its competitors?
Compare TAK to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize TAK's performance and positioning.
What is TAK's stock price target for 2026?
Our AI model provides price targets for TAK based on fundamental analysis: Bull case $23.17 (+30%), Base case $20.49 (+15%), Bear case $16.04 (-10%). Visit our prediction page for detailed forecasts.
What do analysts say about TAK?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for TAK. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is TAK's next earnings report?
TAK reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.